Emerald Health to Sell $25 Million $2 Convertible Notes with 12.5 Million $2 Warrants

Emerald Health Therapeutics Announces $25 Million Convertible Debenture Unit Financing VANCOUVER, British Columbia, Aug. 28, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Investor has agreed, subject to
[Read More ...]

Originally posted on Emerald Health to Sell $25 Million $2 Convertible Notes with 12.5 Million $2 Warrants via Vic Neufeld Medical Marijuana News